City
Epaper

Yechury says there shouldn't be politics over COVID-19 vaccine, urges govt to share scientific proof

By ANI | Updated: January 6, 2021 04:45 IST

Demanding that there should be no politics over the COVID-19 vaccine, CPI-M general secretary Sitaram Yechury has urged the central government to share the scientific proof of the vaccine to start the vaccination drive.

Open in App

Demanding that there should be no politics over the COVID-19 vaccine, CPI-M general secretary Sitaram Yechury has urged the central government to share the scientific proof of the vaccine to start the vaccination drive.

"There should be no politics on COVID-19 vaccine. The politics over vaccines is irrelevant and irresponsible. The politics over it is against humty. The vaccine should be all and for free. The government should share the scientific proof of vaccines and do the vaccination transparently. It should be safe and responsibility of the government," Yechruy told on Tuesday.

"People are dying and everyone wants that the vaccination should start as soon as possible. It is wrong to say that vaccine is coming due to someone's compassion. We condemn it," he added.

Several leaders from the opposition including Congress' Msh Tewari and Samajwadi Party leader Akhilesh Yadav had raised questions over the COVID-19 vaccines.

Yechury alleged that Hyderabad based drug firm Bharat Biotech's COVID-19 vaccine--COVAXIN--has got approval without following due procedure.

"It is dangerous that Bharat Biotech's COVID-19 vaccine got approval for emergency use without due procedure. Doing vaccination in hurry will be very dangerous. The clinical trial for Bharat Biotech's vaccine is incomplete but it got approval, it is dangerous," he said.

Referring to the Pune based firm Serum Institute of India (SII) vaccine--Covishield, Yechury said, "A vaccine has got approval in England based on trials but in India, the trails were not completed. But giving approval for emergency use in India is wrong,"

SII has tied up with Astrazeneca and Oxford University to conduct trials in India and to produce the vaccines in India. The vaccine got the approval for use on December 30 by UK authorities.

On January 2, the Drugs Controller General of India (DCGI) granted permission for restricted use in emergency situations to COVID-19 vaccines of Serum Institute of India and Bharat Biotech.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalEAM Jaishankar, Japanese counterpart Motegi discuss developments in West Asia

MaharashtraAshok Kharat Case: Massive Financial Scam Exposed, ₹63 Crore Fraud Network Busted, 130 Fake Accounts Unearthed

Other SportsCommonwealth Sports delegation visits India to review Ahmedabad 2030 Commonwealth games preparations

BusinessGold ETF inflows decline in March as Middle East tensions weigh in

BusinessWhat It Actually Feels Like to Have Full Camera Control Without a Camera

National Realted Stories

NationalMP observes Nari Shakti Vandan fortnight to create awareness about Women’s Reservation Act

National'Nitish model' will continue, Nishant is future: JD(U) leaders hail MP Nitish Kumar

NationalDelhi Police bust 'hospital & temple' scammer: Kingpin Paro arrested

National"NDRF, SDRF using bore to put their equipment, camera lines, oxygen lines...": Ujjain SP Pradeep Sharma on borewell accident

NationalRBI absorbing Rs 2 lakh crore excess liquidity via reverse repo auction